(MFC) Manulife Financial - Ratings and Ratios

Exchange: NYSE • Country: Canada • Currency: USD • Type: Common Stock • ISIN: CA56501R1064

Insurance, Annuities, Wealth, Asset Management, Banking

EPS (Earnings per Share)

EPS (Earnings per Share) of MFC over the last years for every Quarter: "2020-09": 0.73, "2020-12": 0.74, "2021-03": 0.82, "2021-06": 0.83, "2021-09": 0.76, "2021-12": 0.84, "2022-03": 0.77, "2022-06": 0.78, "2022-09": 0.67, "2022-12": 0.88, "2023-03": 0.79, "2023-06": 0.83, "2023-09": 0.92, "2023-12": 0.92, "2024-03": 0.94, "2024-06": 0.91, "2024-09": 0.72, "2024-12": 1.03, "2025-03": 0.25, "2025-06": 0.95, "2025-09": 1.16,

Revenue

Revenue of MFC over the last years for every Quarter: 2020-09: 12981, 2020-12: 17383, 2021-03: -2077, 2021-06: 25283, 2021-09: 15534, 2021-12: 21101, 2022-03: -4071, 2022-06: -2849, 2022-09: 7349, 2022-12: 14855, 2023-03: 12475, 2023-06: 11889, 2023-09: 9256, 2023-12: 8689, 2024-03: 12551, 2024-06: 12670, 2024-09: 14572, 2024-12: 4218, 2025-03: 9044, 2025-06: 41125, 2025-09: 17309,
Risk via 10d forecast
Volatility 22.0%
Value at Risk 5%th 34.7%
Relative Tail Risk -4.19%
Reward TTM
Sharpe Ratio 0.34
Alpha -3.03
Character TTM
Hurst Exponent 0.321
Beta 1.021
Beta Downside 1.191
Drawdowns 3y
Max DD 16.75%
Mean DD 3.76%
Median DD 3.01%

Description: MFC Manulife Financial September 26, 2025

Manulife Financial Corp (NYSE:MFC) operates globally through three primary segments: Wealth & Asset Management, Insurance & Annuity Products, and Corporate & Other. The Wealth & Asset Management arm delivers investment advice and retirement solutions to retail, institutional, and pension-plan clients via agents, broker-dealers, financial advisors, and bank partners. The Insurance & Annuity Products segment sells life, long-term care, and annuity policies, as well as deposit and credit products, through a mix of agents, brokers, banks, and direct-to-consumer channels. The Corporate & Other segment includes property-and-casualty reinsurance, run-off operations, timberland and agricultural investments, and ancillary services such as brokerage, fund management, and integrated banking.

Key financial indicators from the most recent annual report (2023) show a net income of roughly US $7.4 billion, a return on equity (ROE) of 13 % and a dividend yield near 6.5 %, placing Manulife among the higher-yielding insurers in North America. The company’s capital adequacy ratios-Core Tier 1 at 13.5 % and Total Capital at 19 %-exceed the minimum requirements set by Canadian regulators, providing a buffer against underwriting volatility.

From a macro-economic perspective, Manulife’s earnings are sensitive to interest-rate movements because longer-duration life-insurance liabilities are marked to market; a 100-basis-point rise in rates historically lifts its net interest margin by about 0.8 % (based on a 2022-2023 internal sensitivity analysis). Additionally, the firm’s exposure to the U.S. market-accounting for roughly 45 % of total premiums-means that U.S. mortality trends and healthcare cost inflation are material drivers of future underwriting profitability. In the Asian segment, growth in middle-class wealth is a leading catalyst, but it also introduces currency risk; the 2024 forward FX outlook suggests a potential 2-3 % depreciation of the Canadian dollar relative to the yuan, which could erode reported earnings if not hedged.

For a deeper, data-driven dive into how these drivers translate into valuation metrics, you might explore the analyst dashboards on ValueRay, where scenario-based models can help quantify the impact of interest-rate shifts and currency movements on Manulife’s projected cash flows.

MFC Stock Overview

Market Cap in USD 57,054m
Sub-Industry Life & Health Insurance
IPO / Inception 1999-09-23
Return 12m vs S&P 500 -0.64%
Analyst Rating 3.77 of 5

MFC Dividends

Metric Value
Dividend Yield 3.59%
Yield on Cost 5y 9.15%
Yield CAGR 5y 1.19%
Payout Consistency 94.1%
Payout Ratio 37.0%

MFC Growth Ratios

Metric Value
CAGR 3y 31.54%
CAGR/Max DD Calmar Ratio 1.88
CAGR/Mean DD Pain Ratio 8.38
Current Volume 1539.1k
Average Volume 1774.6k

Piotroski VR‑10 (Strict, 0-10) 5.5

Net Income (5.91b TTM) > 0 and > 6% of Revenue (6% = 4.30b TTM)
FCFTA 0.03 (>2.0%) and ΔFCFTA 0.30pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue -30.75% (prev 45.98%; Δ -76.72pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.03 (>3.0%) and CFO 30.63b > Net Income 5.91b (YES >=105%, WARN >=100%)
Net Debt (-12.40b) to EBITDA (7.33b) ratio: -1.69 <= 3.0 (WARN <= 3.5)
Current Ratio 0.54 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (1.70b) change vs 12m ago -4.44% (target <= -2.0% for YES)
Gross Margin 19.18% (prev -13.54%; Δ 32.72pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 7.24% (prev 5.09%; Δ 2.16pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 5.73 (EBITDA TTM 7.33b / Interest Expense TTM 1.54b) >= 6 (WARN >= 3)

Altman Z'' -0.02

(A) -0.02 = (Total Current Assets 25.79b - Total Current Liabilities 47.83b) / Total Assets 1026.68b
(B) 0.00 = Retained Earnings (Balance) 5.09b / Total Assets 1026.68b
(C) 0.01 = EBIT TTM 8.85b / Avg Total Assets 989.66b
(D) 0.05 = Book Value of Equity 43.86b / Total Liabilities 973.69b
Total Rating: -0.02 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 75.17

1. Piotroski 5.50pt
2. FCF Yield 44.98%
3. FCF Margin 42.72%
4. Debt/Equity 0.26
5. Debt/Ebitda -1.69
6. ROIC - WACC (= 4.34)%
7. RoE 11.54%
8. Rev. Trend 19.37%
9. EPS Trend -12.58%

What is the price of MFC shares?

As of November 25, 2025, the stock is trading at USD 34.87 with a total of 1,539,126 shares traded.
Over the past week, the price has changed by +3.20%, over one month by +7.00%, over three months by +16.00% and over the past year by +12.55%.

Is MFC a buy, sell or hold?

Manulife Financial has received a consensus analysts rating of 3.77. Therefor, it is recommend to hold MFC.
  • Strong Buy: 3
  • Buy: 5
  • Hold: 4
  • Sell: 1
  • Strong Sell: 0

What are the forecasts/targets for the MFC price?

Issuer Target Up/Down from current
Wallstreet Target Price 31.6 -9.5%
Analysts Target Price 31.6 -9.5%
ValueRay Target Price 44.1 26.3%

MFC Fundamental Data Overview November 22, 2025

Market Cap CAD = 80.50b (57.05b USD * 1.4109 USD.CAD)
P/E Trailing = 15.1839
P/E Forward = 10.5708
P/S = 1.7877
P/B = 1.7897
P/EG = 0.7746
Beta = 0.872
Revenue TTM = 71.70b CAD
EBIT TTM = 8.85b CAD
EBITDA TTM = 7.33b CAD
Long Term Debt = 13.43b CAD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 13.43b CAD (from shortLongTermDebtTotal, last quarter)
Net Debt = -12.40b CAD (from netDebt column, last quarter)
Enterprise Value = 68.09b CAD (80.50b + Debt 13.43b - CCE 25.83b)
Interest Coverage Ratio = 5.73 (Ebit TTM 8.85b / Interest Expense TTM 1.54b)
FCF Yield = 44.98% (FCF TTM 30.63b / Enterprise Value 68.09b)
FCF Margin = 42.72% (FCF TTM 30.63b / Revenue TTM 71.70b)
Net Margin = 8.24% (Net Income TTM 5.91b / Revenue TTM 71.70b)
Gross Margin = 19.18% ((Revenue TTM 71.70b - Cost of Revenue TTM 57.95b) / Revenue TTM)
Gross Margin QoQ = 22.24% (prev 9.14%)
Tobins Q-Ratio = 0.07 (Enterprise Value 68.09b / Total Assets 1026.68b)
Interest Expense / Debt = 2.89% (Interest Expense 388.0m / Debt 13.43b)
Taxrate = 13.91% (310.0m / 2.23b)
NOPAT = 7.62b (EBIT 8.85b * (1 - 13.91%))
Current Ratio = 0.54 (Total Current Assets 25.79b / Total Current Liabilities 47.83b)
Debt / Equity = 0.26 (Debt 13.43b / totalStockholderEquity, last quarter 51.44b)
Debt / EBITDA = -1.69 (Net Debt -12.40b / EBITDA 7.33b)
Debt / FCF = -0.41 (Net Debt -12.40b / FCF TTM 30.63b)
Total Stockholder Equity = 51.15b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.58% (Net Income 5.91b / Total Assets 1026.68b)
RoE = 11.54% (Net Income TTM 5.91b / Total Stockholder Equity 51.15b)
RoCE = 13.70% (EBIT 8.85b / Capital Employed (Equity 51.15b + L.T.Debt 13.43b))
RoIC = 13.08% (NOPAT 7.62b / Invested Capital 58.25b)
WACC = 8.74% (E(80.50b)/V(93.92b) * Re(9.78%) + D(13.43b)/V(93.92b) * Rd(2.89%) * (1-Tc(0.14)))
Discount Rate = 9.78% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.88%
[DCF Debug] Terminal Value 75.45% ; FCFE base≈28.59b ; Y1≈34.12b ; Y5≈53.95b
Fair Price DCF = 404.3 (DCF Value 681.29b / Shares Outstanding 1.68b; 5y FCF grow 20.65% → 3.0% )
EPS Correlation: -12.58 | EPS CAGR: 10.57% | SUE: 1.14 | # QB: 1
Revenue Correlation: 19.37 | Revenue CAGR: 5.72% | SUE: 0.44 | # QB: 0

Additional Sources for MFC Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle